* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download The Study of Mechanisms by Which Paclitaxel Activates Stat3
Cell culture wikipedia , lookup
Gene regulatory network wikipedia , lookup
Silencer (genetics) wikipedia , lookup
Cell-penetrating peptide wikipedia , lookup
Gene therapy of the human retina wikipedia , lookup
Endogenous retrovirus wikipedia , lookup
List of types of proteins wikipedia , lookup
Signal transduction wikipedia , lookup
Secreted frizzled-related protein 1 wikipedia , lookup
Transcriptional mechanism of Sp1-mediated genes in A431 cells Jan-Jong Hung, Yi-Ting Wang and Wen-Chang Chang Department of Pharmacology, College of Medicine, National Cheng Kung University Two parts in our study are carried out to characterize the transcriptional mechanism of Sp1-mediated genes. First, Sp1 is a basic transcriptional factor, which binds to the GC-rich region in the promoter of target gene. It is involved in transcription of numerous genes by recruiting other transcriptional factors to the promoters of target genes. In this study, we found in vivo and in vitro that Hsp90 was recruited to the GC-rich region of 12(S)-lipoxygenase promoter by interaction with Sp1 in A431 cells by employing DNA affinity immunoprecipitation assay and chromatin immunoprecipitation assay. When Hsp90 was inhibited by geldanamycin (GA), a specific inhibitor of Hsp90 family, or by siRNA of Hsp90 to block its activity or to knockdown protein level respectively, the luciferase activity driven by the 12(S)-lipoxygenase promoter, and both of mRNA and protein levels of 12(S)-lipoxygenase all were reduced significantly in cells. In addition, the effect of GA was abolished when the Sp1-binding sites of 12(S)-lipoxygenase were mutated in A431 cells. Interestingly, binding of Sp1 to the 12(S)-lipoxygenase promoter was also decreased upon GA treatment in cells. In conclusion, our results indicated that Sp1 interacted with Hsp90 to recruit it to the promoter of 12(S)-lipoxygenase, and then to regulate the gene transcription by affecting the binding ability of Sp1 to the promoters. Second, we previous reported that Sp1 functions as an anchor to recruit c-Jun to the promoter of the 12(S)-lipoxygenase gene when human epidermoid carcinoma A431 cells were stimulated with 12-myristate 13-acetate (PMA) or epidermal growth factor. We now show that Sp1 was constitutively acetylated that recruited HDAC1 to the Sp1/cJun complex when cells were exposed to PMA (3 h). Prolonged stimulation of the cells with PMA (9 h), however, caused the dissociation of HDAC1 and the deacetylation of Sp1 with the latter being able to recruit p300 that in turn caused the acetylation and dissociation of histone 3, thus enhancing the expression of 12(S)-lipoxygenase. To establish a causal relation between the decetylation of Sp1 and the recruitment of p300, we overexpressed Sp1 mutant (K703/A; lacking acetylation sites) in the cell and found that mutant cells recruited more p300 and expressed more 12(S)-lipoxygenase. Our results indicate that the activation of a promoter may require several transcription factors acting in a highly coordinated, temporal-spatial manner. Our results also suggest that transcription factors, as limited in numbers as they are found in nature, can perform formidable arrays of gene regulation in mammals perhaps by landing numerous combinations and/or temporal spatial arrangements at even a single locus on a promoter. The regulatory mechanisms of increased p300 recruitment to the keratin 16 promoter by ERK activation in keratinocytes Ying-Nai Wang, Yun-Ju Chen and Wen-Chang Chang Department of Pharmacology, College of Medicine, National Cheng Kung University In studies of the transcriptional regulation of keratin 16, we have provided a proposed model, indicating that Sp1 recruits c-Jun to the promoter through the binding of Sp1 to the Sp1 site, and coactivators p300/CBP interact with Sp1 and AP1 proteins and participate in the transcriptional regulation for EGF induction of keratin 16 gene expression in keratinocyte HaCaT cells. By using a chromatin immunoprecipitation assay and a DNA affinity precipitation assay, EGF treatment up-regulates p300 recruitment through ERK signaling to the promoter region in regulating keratin 16 transcriptional activity. p300 mediates and regulates EGF-induced keratin 16 gene expression at least in part through multiple mechanisms including a selective acetylation of c-Jun and histone H3. It was reported previously that direct phosphorylation of the coactivator CBP represents a novel mechanism controlling its recruitment to the transcription complex. Furthermore, the documents were found that the transcriptional activity of p300 was stimulated by phenylephrine through p42/p44 MAPK cascade, and the transactivation domain (aa 1572-2370) of p300 was phosphorylated by MAPK in vitro. According to our results, p300 was phosphorylated by ERK activation in vitro and in vivo. However, it is still unclear where the phosphorylation sites occur upon growth factors treatment. More importantly, the functional links between the specific phosphorylation events and the downstream gene regulations remain largely unknown. Whether recruitment of p300 to the keratin 16 promoter by ERK activation was regulated by its phosphorylation state will be further explored. In addition, it has been reported that p300 acts as a scaffold for the cooperation with multiple transcriptional factors such as Sp1. Nevertheless, it remains unknown whether any post-translational modification of Sp1 by EGF treatment occurs and then promotes keratin 16 gene activation by protein-protein interaction with p300. In our system, p300 could interact with Sp1 by using GST-pull down assay in vitro, and a significant binding of co-immunoprecipitated p300 to Sp1 was also observed in cells upon EGF stimulation in vivo. Taken these results together, the enhanced binding of p300 to Sp1 by EGF treatment could be mediated by phosphorylation of p300 through ERK. Therefore, we are interested to further clarify the underlying regulatory mechanisms, such as through physical protein-protein interaction and posttranslational modification, of those nuclear factors involved in the transcriptional control of keratin 16 upon EGF treatment. Functional role of c-Jun/PP2B in regulation of gene expression Ben-Kuen Chen, Chi-Chen Huang and Wen-Chang Chang Department of Pharmacology, College of Medicine, National Cheng Kung University c-Jun/Sp1 interaction is essential for growth factor- and phorbol 12-myristate 13-acetate (PMA)-induced genes expression, including human 12(S)-lipoxygenase, keratin 16, cytosolic phospholipase A2, p21WAF1/CIP1 and neuronal nicotinic acetylcholine receptor 4. We found that the mechanism used to regulate the c-Jun/Sp1 interaction induced by PMA and EGF is mediated by calcineurin (PP2B). Inhibition of calcineurin (PP2B) by using cyclosporin A and PP2B small interfering RNA resulted in attenuating the PMA- and EGF-induced gene expression c-Jun/Sp1 interaction. PP2B bound and dephosphorylated the phospho-TAM-67 interacted with c-Jun in PMA-treated cells. To investigate the function mechanism involved in the regulation of c-Jun/PP2B complex, EGF- and and and and PMA-induced protein modification was analyzed. EGF induced GSK3 phosphorylation but no change in GSK3/Sp1 complex. PMA but not EGF induced MAPK phosphorylation was inhibited in cells treated with PP2B, HDAC and GSK3 inhibitors. Theses results suggested that c-Jun/PP2B may play different function in EGF- and PMA-induced gene expression. Regulation of gene expression by the VDR/Sp1 complex Yu-Chun Huang, Jin-Yi Chen, Hsuen-Tsen Cheng and Wen-Chun Hung Graduate Institute of Medicine, Kaohsiung Medical University and Institute of Biomedical Sciences, National Sun Yat-Sen University Recent studies show that lipophilic hormones may induce expression of target genes in which no hormone receptor response elements are found in their promoter regions. These results suggest that nuclear receptors may physically interact with classic transcription factors to activate gene expression. We have previously demonstrated that vitamin D3 may stimulate the interaction between VDR and transcription factor Sp1 to activate the expression of a cyclin-dependent inhibitor p27Kip1 and to suppress proliferation of cancer cells. We extend our finding and try to answer the molecular mechanism by which the VDR/Sp1 complex regulates gene expression. Our results suggest that Sp1 functions as an anchor protein to bring VDR to the Sp1 binding site in the p27Kip1 promoter and VDR then recruits the co-activators via its activation domain to stimulate p27Kip1 gene expression. We also identify that VDR/Sp1 complex can activate CD14 via similar mechanism. Therefore, p27Kip1 and CD14 are molecular targets that positively regulated by the VDR/Sp1 complex. Microarray analysis identifies several potential target genes which expression may be inhibited by the VDR/Sp1 complex. We identify the expression of Skp-2, an important regulator that mediates p27Kip1 protein degradation and a potential oncogene, is suppressed by vitamin D3. We clone the human Skp-2 promoter and demonstrate that vitamin D3 inhibits Skp-2 via Sp1 binding sites. Moreover, our results indicate that vitamin D3 enhances the formation of VDR/Sp1 complex to repress Skp-2. Taken together, our study suggests that VDR may form the VDR/Sp1 complex and modulate gene expression via the Sp1 site in the promoter. Post-transcriptional regulation of thrombomodulin Joseph T. Tseng and Wen-Chang Chang Department of Pharmacology, College of Medicine, National Cheng Kung University Thrombomodulin (TM), recognized as an important anticoagulant factor, is also expressed by a wide range of tumor cells. Overexpression of wild-type TM decreases cell proliferation in vitro and tumor growth in vivo. The cDNA sequence of TM showes a very long 3’ untranslated region (around 2 Kbps). However, the functional role of this region involved in the regulation of TM expression is not cleared. Here we showed that the EGF-induced upregulation of TM mRNA in human cervical cancer cell line A431 is accompanied by stabilization (around 2-fold) of TM mRNA. From the RNA-EMSA experiment, we identified a UC-rich region in the 3’-UTR of thrombomodulin mRNA binding with the protein complex. It indicated this region involved in the regulation of mRNA stability of TM. Furthermore, four major binding proteins HuR, poly(C)-binding protein (PCBP), heterogeneous nuclear ribonucleoprotein K (hnRNP-K) and polypyrimidine tract-binding protein 1 (PTBP1 or hnRNP-I) were identified by UV-crosslinking assay and mass spectrometry. Regarding the signal pathway for regulating the TM mRNA stability, Ly294002, a PI3-Kinase inhibitor, was shown to block the stabilization mechanism and enhance the degradation of TM mRNA. Therefore, PI3-Kinase played an important role in mediating the EGF signal induced mRNA stability. The mechanism for nuclear translocalization of RON receptor in human bladder carcinogenesis Pei-Yin Hsu1, Nan-Haw Chow2 and Hsiao-Sheng Liu3 1 Institute of Basic Medical Sciences, 2 Department of Pathology, 3 Department of Microbiology and Immunology, College of Medicine, Nation Cheng Kung University RON (Recepteur d’Origine Nantais) is a distinct receptor tyrosine kinase in the MET proto-oncogene family. A number of studies have described the potential significance of RON overexpression in epithelial carcinomas. We recently demonstrated that MSP/RON-associated signaling is important in the progression of human bladder cancer. Intriguingly, both wild-typed and truncated forms of RON were observed in the nuclei. This study was thus designed to explore the molecular basis underlying the nuclear translocalization of RON in human bladder carcinogenesis. Both wild-typed and truncated forms of RON were demonstrated in the nuclear fraction of cancer cells at de-phosphorylated status via a ligand-independent manner. Nuclear RON was also colocalized with importin 1, 1 and de-phosphorylated EGFR. However MSP treatment resulted in phosphorylation of EGFR accompanied by dissociation from RON in the nuclei, implying a cross-talk between RON and EGFR. The siRNA experiments confirmed the importance of EGFR for nuclear translocalization of RON. Then site-directed mutagenesis assay on N- and/or C-terminal nuclear localization signals (NLSs) of RON was performed to clarify the significance of NLS in the nuclear translocalization of RON. Preliminary results showed that R306Q at N-terminal, and both R1388T and R1389T at C-terminal NLS of RON effectively suppressed the nuclear translocalization of RON, supporting the involvement of NLS in the nuclear localization of the receptor protein. Moreover, both proliferation and anti-apoptotic effects were suppressed in NLS mutants compared with wild-typed transfectants, suggesting the importance of nuclear RON in the cell proliferation and anti-apoptosis. Given that heat shock proteins (HSPs) were shown to be the chaperones in regulating stress-induced signaling and nuclear transport of cell cycle kinases, we assayed their expression in the subcellular fraction by immunoblotting. Levels of HSP70, HSP90 and heat shock factor 1 (HSF 1) were all increased in the cell nuclei. Further study is underway to examine their biological significance for nuclear RON/EGFR complex in human bladder cancer. Eps8 regulates Src/FAK activity in colorectal cancer cells Tzeng-Horng Leu1, Ming-Chei Maa2, Jenq-Chang Lee3, Yun-Ju Chen1, Yen-Jen Chen1, Ching-Chung Huang1, Shan-Tair Wang4, Nan-Haw Chow5 and Yuan Liu1 1 Department of Pharmacology, 3Surgery, 4 Public Health, and 5 Pathology, College of Medicine, National Cheng Kung University, 2 Institute of Biochemistry, Chung Shan Medical University Eps8, a common substrate for both receptor and nonreceptor tyrosine kinases, has been characterized as an oncoprotein and participates in Src-mediated transformation in murine fibroblasts. However, to date, its involvement in human cancers is still obscure. In this study, we observe the overexpression of Eps8 in both human colon cancer cell lines and human colorectal tumor specimens. Interestingly, as compared to cells with low Eps8 expression (i.e. SW480 and HCT116), elevated FAK expression, ERK activation, and growth rate are detected in cells with high Eps8 expression (i.e. SW620 and WiDr), implicating the critical role of Eps8 expression in colon cancer formation. Indeed, reduced cell proliferation in culture and tumor growth in nude mice is observed in SW620 cells bearing eps8-siRNA. Surprisingly, a statistically strong correlation between the expression of Eps8 and FAK is also observed in human colon tumor specimens. In addition, Eps8 knockdown of SW620 cells not only decreased FAK expression but also reduced Src-mediated FAK phosphorylation on Tyr-863 and –577, resulting in the decrease of FAK Tyr-397 phosphorylation. In agreement with its role in mitogenesis, overexpression of dominant negative FAK (i.e. FRNK) reduced BrdU incorporation of both SW620 and WiDr cells and ectopical expression of FAK in cells with eps8-siRNA restored cellular growth. We thus conclude that Eps8 overexpression in human colon cancer cells facilitates their proliferation by upregulation and activation of FAK. The study of mechanisms by which paclitaxel activates Stat3 protein in lung cancer cells Ya-Chin Lo, I-Huei Tu, Hsuan-Heng Yeh and Wu-Chou Su Department of Internal Medicine, College of Medicine, National Cheng Kung University Stat3, one of the 7 known STAT (Signal Transducers and Activators of Transcription) family members, is frequently constitutively activated in malignant cells1. Activation of Stat3 is involved in regulating many genes such as cell cycle progression, cellular proliferation and survival. In our system, constitutively activated Stat3 in human lung adenocarcinoma cell line --PC14PE6/AS2, mediated by IL6/gp130/Jak2 pathway, was demonstrated. Upon treatment with anti-cancer agents, the activation of Stat3 in PC14PE6/AS2 cells was enhanced at earlier period (around 3 hours), and then declined gradually. The further activation of Stat3 in PC14PE6/AS2 cells by paclitaxel could be abolished by adding Jak2 inhibitor – AG490 – indicates that Jak2 mediates the reaction. For the mechanisms underlying the activation of Jak2 by anticancer agents, we suspect the induction of ROS and subsequent deactivation of tyrosine phosphatase may play a role. Using the redox-sensitive fluorescence probe DCFH-DA, we found that anti-cancer agent, paclitaxel, stimulates ROS production in PC14PE6/AS2 cells. Generation of ROS was suppressed by diphenylene iodonium (DPI), an inhibitor of flavoprotein-dependent oxidases, Rotenone, an inhibitor of mitochondrial respiratory chain complex I, and Antimycin A, an inhibitor of mitochondrial respiratory chain complex III. The activation of Stat3 in PC14PE6/AS2 cells by paclitaxel is also inhibited by the pretreatment of the above three compounds. Other inhibitors of NAC or catalase did not abolish Stat3 activation by paclitaxel. Taken together, paclitaxel induces ROS generation is likely through a mitochondrial-mediated pathway. In the other part, we suspect that generation of ROS by paclitaxel may transiently inactivate PTP-1B and then switch the equilibrium towards autophosphorylation of Jak kinases. Although this phenomenon was not observed, we found another pathway may partially involved STAT3 activation induced by paclitaxel. H2O2-induced activation of PKC- is reported to be independent from tyrosine phosphatase inhibition. Inhibition of PKC- rottlerin supported that PKC- kinase activity is required for both baseline and paclitaxel-induced STAT3 tyrosine phosphorylation. The paclitaxel-induced STAT3 activation resulted in upregulation of Bcl-2 protein, which may contribute to the relatively resistant to paclitaxel in PC14PE6/AS2 than in A549 cells. With a better understanding of how anticancer agents regulate Stat3 activation, we may have chances to find new targets for overcoming tumor drug resistance. HBV pre-S2 mutant and endoplasmic reticulum stress signaling pathways Yung-Mei Chao, Yung-Sheng Chang, Ih-Jen Su, Huan-Yao Lei, Wen-Tsan Chang, Wenya Huang, Jui-Hsiung Huang, Hui-Ching Wang, Wen-Chang Chang and Ming-Derg Lai Department of Biochemistry and Department of Basic Medicine, College of Medicine, National Cheng Kung University The expression of HBV pre-S2 mutant has been associated with the development of hepatocarcinoma. Endoplasmic reticulum stress induced by HBV pre-S2 mutant may play a role in carcinogenesis and genomic instability. In this report, we investigated the possible signal pathways resulting from the HBV pre-S2 mutant or endoplasmic reticulum stress. Since c-Jun is important for hepatocyte development, we first studied whether there is a linkage between HBV pre-S2 mutant, ER stress, and c-Jun. Tunicamycin, and brefeldin A, two ER stress inducers, increased the expression of c-Jun in ML-1 cells. Expression of HBV pre-S2 mutant also enhanced the expression of c-Jun in ML-1 cells. Furthermore, one of the c-Jun-regulated genes, MMP-9 was induced under ER stress and the expression of HBV-large surface proteins. Enhanced binding of c-Jun on the promoter of MMP-9 gene was demonstrated by EMSA and CHIP. In addition, the migration ability of ML-1 cells expressing HBV pre-S2 mutant was higher than that of ML-1 cells expressing wild-type HBV large surface proteins. In the future, our laboratory will focus on several interesting topics: (1) what is the mechanism of enhanced migration in cells expressing HBV pre-S2 mutant? (2) Does lipid biosynthesis play a role in causing carcinogenesis? (3) How does HBV pre-S2 affects the transcriptional factor and coactivator through ER stress? The role of HBV pre-S2 mutant protein in hepatocarcinogenesis Hui-Ching Wang, Jui-Chu Yang and Ih-Jen Su Division of Clinical Research, National Health Research Institutes, Tainan Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University In past few years, we have demonstrated that pre-S2 mutant protein (S2-LHBs) could serve as a tumor promoter that contributes to carcinogenesis via either gene transactivation or ER stress signaling. The inductions of cyclin A in both liver tissues and transgenic mice by S2-LHBs have shown biological impacts on liver nodular proliferation and hepatocyte multinucleation. Since gene expression of cyclin A is regulated by RB/E2F pathway during G1 phase of cell cycle, it is important to evaluate whether this signal pathway is affected by S2-LHBs protein. On HuH-7 cells, hyperphosphorylated form of RB is increased by S2-LHBs as demonstrated by Western Blotting. Although the exact phosphorylation site on RB induced by S2-LHBs remains further examination, we have evidence showing that DNA cytosine-5 methyltransferase 1 (DNMT1) may be induced by the release of E2F1 from RB. Since DNMT1 is required in maintaining DNA methylation in both normal and cancer cells, the induction of DNMT1 may represent an epigenetic cause of cancer in the development of hepatocellular carcinoma. Recently, we have also demonstrated that S2-LHBs can induce tumor formation on the transgenic mice model when established on the genetic background of C57/B6 strain. The successfully induction of liver tumors on transgenic mice may therefore provide us more information to study the carcinogenic pathway involving in HBV pre-S mutants during the development of hepatocellular carcinoma. Characterization of a small size peptide Zfra that regulates stress responses by functionally interacting with WOX1 and JNK1 Li-Jin Hsu1, Yee-Shin Lin1 and Nan-Shan Chang2 1 Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan; 2Laboratory of Molecular Immunology, Guthrie Research Institute, Sayre, Pennsylvania, USA Here, we isolated an unusual gene transcript encoding a 31-amino-acid zinc finger-like protein or peptide that regulates apoptosis (named Zfra). Northern blotting and RT/PCR showed the transcript is abundant in spleen but absent in several prostate and breast cancer cells. Presence of Zfra protein was evidenced by in vitro translation, immunoprecipitation, and isoelectric focusing. Transiently overexpressed Zfra induced apoptosis, and that phosphorylation of Ser8 is essential for its apoptotic function. Depending upon the extent of expression, Zfra could either enhance or block the cytotoxic effect of death domain proteins TRADD, FADD and RIP of the TNF and FasL signaling pathways. Mechanistically, TNF and UV light induce Zfra to rapidly selfassociate and bind WOX1, JNK1 and NF-B (p65). The tumor suppressor p53 weakly interacted with Zfra. Ectopic Zfra blocks phosphorylation and nuclear translocation of WOX1, JNK1 and p53 and their apoptotic effects in certain cells. In contrast, a Ser8 mutant of Zfra has no blocking effect. Together, Zfra is a novel small size peptide that functionally interacts with downstream effectors WOX1, JNK1, p53 and NF-B of the TNF and stress pathways. Discussion for the Fas-mediated apoptosis of immune T cell reduced by tumor cell Chung-Chen Su, Yu-Ping Lin and Bei-Chang Yang Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University FasL expression on tumor cells engaged with the Fas protein of tumor infiltrating lymphocytes (TILs) will trigger death signal to lead these cells into apoptosis. We established a model system to utilize immune cells cocultured with tumor cells and simulated the specific environment of tumor nodule to investigate the affection of ECM or adhesion molecular on Fas-mediated apoptosis of TILs. As human Jurkat T cells were cocultured with glioma through cell-cell direct contact, the sensitivity of apoptosis in Jurkat T cells induced by CH-11 (anti-human Fas monoclonal antibody) was reduced. The biochemical activities involved in apoptosis, such as activation of caspase-8, -9, or –3 and DNA fragmentation are reduced by cocultured with glioma cells. In addition, tumor cells will reduce the activation-induced cell death process of activated peripheral T cell in blood. Furthermore, kinases activity of immune cells can be activated through the interaction of ECM and integrins. Our previous result showed that phosphorylation of Erk 1/2 and p38 MAPK activated by treating CH-11 alone or cocultured with glioma cells but inhibition of Erk 1/2 or p38 MAPK phosphorylation does not affect the reduction of CH-11-induced cell death in Jurkat T cells by glioma. CH-11 reduces the AKT phosphorylation of Jurkat T cells, but recover to basal level under cocultured with glioma. Recently, we found that phosphorylation of Erk 1/2, p38 MAPK and JNK were strong enhanced but the CH-11-induced cell death of Jurkat T cells did not reduce when MCF-7 existence. Altogether, the roles of kinase activity play in immune cells through cell-cell direct contact to reduce the Fas-mediated death signaling transduction remain to be clarified. Second part of the project showed that engagement of Fas with CH-11 induced the phosphorylation of p38 MAPK in Jurkat T cells. No new protein synthesis was required for the Fas-mediated phosphorylation of p38 MAPK. Inactivation of caspase-8 by specific inhibitor Z-IETD reduced the phosphorylation of p38 MAPK induced by CH-11. Suppression of p38 MAPK activity significantly enhanced the Fas-mediated apoptosis. Moreover, Fas-associated caspase-8 and caspase-3 induction were enhanced by the inhibition of p38 MAPK. The enhanced activation of caspase-3 upon Fas signaling by SB202190 was completely blocked by Fas antagonistic antibody ZB4 or caspase-8 inhibitor Z-IETD indicating that the influence of p38 MAPK on caspase-3 was specific in Fas signaling. The involvement of p38 MAPK in Fas-mediated apoptosis was also observed in peripheral activated-T cells. The expression of pP38 in fresh T cells and non-activated T cells were more than activated-T cells supporting that containing more pP38 may be resistance to Fas-mediated apoptosis. In summary, the activation of p38 MAPK by Fas signal was an auto feedback pathway that prevents the death event in T cells. Low substratum rigidity down-regulates FAK397 phosphorylation and 1 integrin by different ways Wei-Chun Wei and Ming-Jer Tang Department of Physiology, College of Medicine, National Cheng Kung University Previous study demonstrated that cells cultured on collagen gel displayed down-regulation of focal adhesion proteins induced by low rigidity. In this study, we found that when MDCK cells were cultured on collagen gel, the FAK397 phosphorylation ratio was decreased while other phosphorylation sites (407, 577, 861, and 925) of FAK remained activated. We also checked the level of 1 integrin activation which is the upstream signal of FAK. 1 integrin activation was down-regulated under low substratum rigidity. To analyze whether FAK and DDR1, another collagen receptor, were involved in the “in-side-out” signal of 1 integrin activation, wild type and dominant negative FAK or DDR1 stably transfected MDCK cells were employed. We found that low rigidity induced down-regulation of 1 integrin activation and FAK397 phosphorylation was not altered by FAK or DDR1. To elucidate whether the internal force provided from actin filaments and microtubules affected 1 integrin activation and FAK397 phosphorylation, we employed cytochalasin D and colcemide. Disruption of actin cytoskeleton by cytochalasin D blocked FAK397 phosphorylation but not 1 integrin activation while disruption of microtubules by colcemide had no effect. Immunofluorescence showed that active 1 integrin was colocalized with lipid raft in cells cultured on collagen-coated dish. Furthermore, MCD, a lipid raft inhibitor, inhibited 1 integrin activation in cells cultured on rigid substratum. However, MCD did not affect the level of FAK397 phosphorylation. Taken together, our data provides a new concept that collagen fibril-induced FAK397 phosphorylation needs internal force provided from actin filaments. On the other hand, 1 integrin activation requires preferentially external force from rigid substratum, which is regulated by lipid raft. ER stress is involved in apoptosis induced by low substratum rigidity Wen-Tai Chiu1, Meng-Ru Shen2, 3, Yao-Hsien Wang1 and Ming-Jer Tang1, 4 1 Institute of Basic Medical Sciences, 2Department of Pharmacology, 3Department of Obstetrics & Gynecology, 4Department of Physiology, College of Medicine, National Cheng Kung University Mechanical probing of the immediate environment is considered a critical mechanism controlling several cellular processes, such as motility, morphogenesis, proliferation, and apoptosis. Our previous studies have showed that collagen gel induced apoptosis in epithelial cells, but not in mesenchymal cells and tumor cells. This kind of cell apoptosis was mediated by the physical property of low-substratum rigidity, but the mechanisms that cells senses the substratum rigidity remain poorly understood. Here, we investigated the underlying mechanism of low-substratum rigidity induced apoptosis. ER stress-specific caspase-12 and effector caspase-3 were activated in LLC-PK1 cells when cultured on collagen gel. Down-regulation of ER-resident Ca2+ buffering proteins (calregulin and calnexin) and activation of calcium-activated cysteine protease (-calpain) were also noted. Collagen gel also caused ER-Ca2+ overloading which subsequently up-regulated capacitative calcium entry. Both CCE inhibitors (BEL and 2-APB) and intracellular Ca2+ chelator (BAPTA-AM) could inhibit significantly collagen gel-induced -calpain activation and apoptosis in LLC-PK1 cells. This indicates that the disturbance of intracellular Ca2+ homeostasis likely contributes to ER stress leading to low-substratum rigidity induced apoptosis. In conclusion, collagen gel-induced ER stress is involved in low substratum rigidity-induced epithelial cell apoptosis. Dysregulation of Ca2+ homeostasis may play an important role in this phenomenon. Deregulation of AP-1 protein family in collagen gel–induced apoptosis mediated by low substratum rigidity Yao-Hsien Wang1, Wen-Tai Chiu1, Yang-Kao Wang2, Pei-Jun Hsieh2 and Ming-Jer Tang1, 2 1 Institute of Basic Medical Sciences, 2Department of Physiology, College of Medicine, National Cheng Kung University In order to delineate how the substratum rigidity controlled cell life and death, we employed cell cultures on type I collagen gel or collagen gel-coated dish. Here we established that collagen gel, but not collagen gel-coating, induced apoptosis of epithelial (NMuMG, BS-C-1, LLC-PK1, NRK-52E and BAEC) but not mesenchymal (HEK 293 and NIH-3T3) or tumor (HK-2, U-373MG, OC-2, DOK, SSC-25, HSC-3 and Chang Liver) cell lines, indicating that low substratum rigidity may be the cause of apoptosis. To delineate whether rigidity of collagen gel controlled epithelial cell apoptosis, we employed collagen gels harboring different rigidity due to cross-linking or physical disruption of collagen fibrils. We found that collagen gel prepared from older rat ameliorated contracted morphology and apoptosis. On the other hand, a reduction in rigidity by sonication of collagen fibrils augmented collagen gel-induced apoptosis. As assessed by rheometry, the rigidity of collagen gel, ranged from 10 to 120 Pascal, was elevated by age effects and lowered by sonication. Bcl-2 overexpression did not prevent low rigidity-induced apoptosis and mitochondria release of cytochrome c was not observed during cell apoptosis, indicating that the mitochondrial pathway is not involved in low rigidity-induced apoptosis. Low rigidity triggered activation of JNK within 4 h. In addition, low rigidity induced rapid down-regulation of c-Jun, a downstream signal protein of JNK, within 1 h and triggered aberrant expression of c-Fos, which lasted for at least 24 h. Both reduction of c-Jun expression by si-RNA and overexpression of c-Fos could induce apoptosis in several epithelial cells. Inhibition of low rigidity-induced JNK activation by SP600125 could prevent aberrant c-Fos expression, but only partially blocked low rigidity-induced apoptosis. Taken together, we conclude that low substratum rigidity induces apoptosis in epithelial cells, which is mediated at least in part by deregulation of AP-1 proteins. Molecular mechanism of ceramide-induced apoptosis and anti-apoptotic role of lithium Yee-Shin Lin, Chiou-Feng Lin, Chia-Ling Chen, Ming-Shiou Jan, Li-Jin Hsu, Peng-Ju Chien and Chi-Wu Chiang Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University Ceramide, a product of sphingolipid metabolism, functions as intracellular second messenger in response to various stress stimuli, such as tumor necrosis factor-, Fas, chemotherapeutic agents, and irradiation. Ceramide may modulate the biochemical and cellular processes that lead to apoptosis. However, the mechanisms by which ceramide regulates apoptotic events are not fully defined. We recently show that sequential activation of caspase-2 and -8 is essential for ceramide-induced mitochondrial apoptosis. Bcl-2 rescues ceramide-induced apoptosis through blockage of caspase-2 activation. Protein phosphatase 2A (PP2A)-mediated Bcl-2 dephosphorylation is involved in caspase-2 activation induced by ceramide. Our previous results showed that lithium conferred protection against ceramide-induced apoptosis by promoting MEK/ERK and inhibiting caspase-2 and -8 activation. Furthermore, lithium blocked ceramide-induced apoptosis via inhibition of PP2A activity. Ceramide-induced PP2A activation involved methylation of PP2A C subunit, which was inhibited by lithium. Lithium caused dissociation of the PP2A B subunit from the PP2A core enzyme, whereas ceramide caused recruitment of the B subunit. Further study showed the dependence of GSK-3 in ceramide-induced mitochondrial apoptosis. The PP2A-regulated PI3K/Akt signaling was involved in GSK-3 activation by ceramide, which lithium suppressed. Microarray analysis showed that ceramide upregulated thioredoxin-interacting protein (TXNIP) expression, whereas lithium downregulated its expression. The preliminary results suggest the involvement of TXNIP in p38- and JNK-mediated apoptotic signaling pathways. Taken together, our studies show both transcription-independent and transcription-dependent pathways of ceramide-induced apoptotic cell death, and lithium confers an anti-apoptotic effect in both pathways.